Ipafricept (OMP-54F28) is a FZD8 decoy receptor that binds WNTs and has been tested as both a monotherapy in solid tumors and dual therapy for HCC, ovarian cancer, and pancreatic cancer [148, 149]. This evidence concerns the gene FZD8 and pancreatic neoplasm.